Skip to main content
. 2018 Jun 21;27(5):e12862. doi: 10.1111/ecc.12862

Table 5.

Health care resource use related to metastatic SCCHN, overall

During systemic therapy, N = 220 (100.0%) For supportive care after end of last systemic therapy, n = 164 (74.5%)
Number (%) of patients
Outpatient office visitsa 154 (70.0) 83 (50.6)
Outpatient hospital clinic or cancer centre visits 77 (35.0) 60 (36.6)
ED visits 45 (20.5) 23 (14.0)
Palliative care visits in outpatientb, community health service, or home settings 98 (44.6) 59 (36.0)
Hospitalisations (overnight or day admissions excluding ED visits) 59 (26.8) 14 (8.5)
Hospice, long‐term care, or other end‐of‐life/palliative care services 18 (8.2) 31 (18.9)
Mean (SD) number of visits (among patients with any visits)
Outpatient office visitsa 24.8 (13.7) 3.4 (2.4)
Outpatient hospital clinic or cancer centre visits 7.9 (6.1) 3.3 (2.5)
ED visits 1.8 (1.2) 1.4 (0.8)
Palliative care visits in outpatientb, community health service, or home settings 3.8 (3.0) 3.1 (2.0)
Hospitalisations (overnight or day admissions excluding ED visits) 2.9 (2.8) 1.1 (0.3)
Hospice, long‐term care, or other end‐of‐life/palliative care services 1.2 (0.4) 1.6 (0.6)

ED: emergency department; SCCHN: squamous cell carcinoma of the head and neck; SD: standard deviation.

a

Outpatient office visits included visits/consults at the responding physician's office, with a general practitioner, or at a free‐standing oncology clinic.

b

Outpatient palliative care visit settings excluded those settings already captured (i.e., visits to the responding physician's office, with a general practitioner, or at a free‐standing oncology clinic, hospital clinic, or cancer centre).